Hemorrhagic Fever News and Research

RSS
Viral hemorrhagic fevers (VHFs) refer to a group of illnesses that are caused by several distinct families of viruses. In general, the term "viral hemorrhagic fever" is used to describe a severe multisystem syndrome (multisystem in that multiple organ systems in the body are affected). Characteristically, the overall vascular system is damaged, and the body's ability to regulate itself is impaired. These symptoms are often accompanied by hemorrhage (bleeding); however, the bleeding is itself rarely life-threatening. While some types of hemorrhagic fever viruses can cause relatively mild illnesses, many of these viruses cause severe, life-threatening disease.
Study offers new insights into transmission of dengue infections

Study offers new insights into transmission of dengue infections

Majority of dengue virus infections appear to happen very close to home

Majority of dengue virus infections appear to happen very close to home

Pre-existing immunity to dengue virus modulates T cell response to Zika infection

Pre-existing immunity to dengue virus modulates T cell response to Zika infection

Research sheds new light on how dengue virus inflicts more damage during subsequent infections

Research sheds new light on how dengue virus inflicts more damage during subsequent infections

Georgia State University, GeoVax join forces to advance development of Hepatitis B therapeutic vaccine

Georgia State University, GeoVax join forces to advance development of Hepatitis B therapeutic vaccine

Approved dengue vaccine may increase infection in certain settings, research suggests

Approved dengue vaccine may increase infection in certain settings, research suggests

TSRI scientists zoom in to view how experimental therapy ZMapp targets Ebola virus

TSRI scientists zoom in to view how experimental therapy ZMapp targets Ebola virus

Scientists discover modified human protein involved in Ebola virus replication

Scientists discover modified human protein involved in Ebola virus replication

Soligenix announces encouraging preliminary results of heat stable Ebola vaccine

Soligenix announces encouraging preliminary results of heat stable Ebola vaccine

RVFV uses cancer pathway to hijack host cell and cause infection

RVFV uses cancer pathway to hijack host cell and cause infection

Study sheds light on several aspects of Ebola virus flare-ups in Liberia

Study sheds light on several aspects of Ebola virus flare-ups in Liberia

Alternative policy for Ebola entry screening at U.S. airports

Alternative policy for Ebola entry screening at U.S. airports

Findings could be final puzzle piece in developing effective dengue vaccine

Findings could be final puzzle piece in developing effective dengue vaccine

Single antibody could hold promise as potential treatment for human cases of EVD

Single antibody could hold promise as potential treatment for human cases of EVD

Researchers identify, isolate and characterize two Ebola virus neutralizing monoclonal antibodies

Researchers identify, isolate and characterize two Ebola virus neutralizing monoclonal antibodies

Profectus begins Phase 1 clinical study of VesiculoVax-vectored Ebola virus vaccine

Profectus begins Phase 1 clinical study of VesiculoVax-vectored Ebola virus vaccine

Researchers engineer antibodies that could potently neutralize two deadliest strains of Ebola virus

Researchers engineer antibodies that could potently neutralize two deadliest strains of Ebola virus

Ebola health-care workers develop guidelines for treating children during future outbreaks

Ebola health-care workers develop guidelines for treating children during future outbreaks

People with viral infections and identical gene mutations may be prone to hyperinflammatory disorder

People with viral infections and identical gene mutations may be prone to hyperinflammatory disorder

Researchers successfully test new method for rapid diagnosis of Ebola in Guinea

Researchers successfully test new method for rapid diagnosis of Ebola in Guinea